CLEOPATRA

from OncoPharm · host John Bossaer

Our Landmarks of OncoPharm series returns to discuss the CLEOPATRA study, which established docetaxel, trastuzumab, pertuzumab (THP) as a standard first-line regimen for metastatic HER2-amplified breast cancer.

Episode metadata supplied by the publisher feed · Published May 29, 2025

Embed this episode

Attribution link and audio player

Ready to play

CLEOPATRA

0:00 11:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of OncoPharm?

This episode is 11 minutes long.

When was this OncoPharm episode published?

This episode was published on May 29, 2025.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!